MIA researchers awarded $7.2m in NHMRC grants for health research
15 September 2021
We are pleased and proud to announce that Melanoma Institute Australia's world leading researchers at University of Sydney - Prof Georgina Long AO, Assoc Prof Alex Menzies and Professor Anne Cust - received National Health and Medical Research Council (NHMRC) grants today to further their melanoma research, taking us closer to achieving our mission of zero deaths from melanoma this decade.
Prof Georgina Long AO was awarded $3.9 million for 'Towards Zero Deaths from Melanoma: Innovative Clinical Trials with Multi-omics Analyses'. The project will develop new drug therapies using innovative clinical trial designs, collecting unique samples to understand the causes, and conquer drug resistance.
Assoc Prof Alex Menzies was awarded $1.3 million for 'Predictive biomarkers of response, resistance and toxicity with immunotherapy in melanoma'.
Prof Anne Cust was awarded $2 million for 'Tailored approaches to improve prevention and early detection of melanoma and other skin cancers'.
These successful grants demonstrate the outstanding work of our researchers and the potential impact of their projects.
Melanoma Institute Australia is affiliated with The University of Sydney.
The 2021 Australasian Melanoma Conference (AMC2021) will held in Sydney, Australia.
Drug therapy set to become standard treatment in high-risk early stage patients to stop disease spread
We are excited to announce a return to our much-loved physical Melanoma March events in March 2022!
Over two fun, yet challenging, days in September an intrepid group of riders and crew successfully completed the annual Melanoma Bike Bash in WA!
Prof Long AO has been recognised by Australian Academy of Health and Medical Sciences for her transformative work advancing melanoma treatments.
Three MIA researchers at University of Sydney received grants to further their important melanoma research.
COVID restrictions continue to impact fundraising for melanoma services in Riverina.
Ben Garrow lost his life to melanoma. In his honour his family has established a scholarship to support a PhD student whose work focuses on saving lives from melanoma.
More than 150 clinicians, researchers and MIA staff gathered online to share research highlights.
Independent researchers at The University of Sydney are seeking patient feedback.
A re-cap of the wonderful, and often very creative, community fundraising initiatives over the April to June quarter.
Our patients who donate their tissue samples and records to our research are helping to make a difference to the lives of future melanoma patients.
MIA researchers have recently been awarded two competitive funding grants, which will help facilitate their ground-breaking work in melanoma research.
Celebrate the 10th anniversary of Amie St Clair Melanoma at the Annual Ball in Wagga Wagga!
Postponed to early 2022. Melanoma survivor Matt Kean is doing a 1000km bike ride around the Riverina to increase awareness of melanoma and raise funds for Amie St Clair Melanoma - MIA. There are many ways you can be part of this life-changing ride!
Riverina patients gain access to potentially life saving immunotherapy treatment close to home.
MIA's Prof Scolyer has been appointed as an Officer (AO) of the Order of Australia.
In a breakthrough which could extend to the treatment of other cancers, a new immune checkpoint inhibitor has proven effective in helping save the lives of advanced melanoma patients.
Whilst our research and clinical teams are trialling new treatments to save lives, it is our nurses who are on the front line providing care and support.